ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy

Xiang, Jing; Ma, Lin; Tong, Jianfei; Zuo, Nan; Hu, Weitao; Luo, Yupeng; Liu, Junqi; Liang, Tianjiao; Ren, Qiushi*; Liu, Qi*北京大学; 哈尔滨医科大学; 郑州大学; 杭州师范大学; 中国科学院; 1
Frontiers in Medicine2023-6-1DOI: 10.3389/fmed.2023.1199881
11阅读
引用收藏
分享

摘要

Boron neutron capture therapy (BNCT) induces intracellular nuclear reaction to destroy cancer cells during thermal neutron irradiation. To selectively eliminate cancer cells but avoid harmful effects on normal tissues, novel boron-peptide conjugates with angiopep-2, namely ANG-B, were constructed and evaluated in preclinical settings. Boron-peptide conjugates were synthesized using solid-phase peptide synthesis, and the molecular mass was validated by mass spectrometry afterwards. Boron concentrations in 6 cancer cell lines and an intracranial glioma mouse model after treatments were analyzed by inductively coupled plasma atomic emission spectroscopy (ICP-AES). Phenylalanine (BPA) was tested in parallel for comparison. In vitro treatment with boron delivery peptides significantly increased boron uptake in cancer cells. BNCT with 5 mM ANG-B caused 86.5% +/- 5.3% of clonogenic cell death, while BPA at the same concentration caused 73.3% +/- 6.0% clonogenic cell death. The in vivo effect of ANG-B in an intracranial glioma mouse model was evaluated by PET/CT imaging at 31 days after BNCT. The mouse glioma tumours in the ANG-B-treated group were shrunk by 62.9% on average, while the BPA-treated tumours shrank by only 23.0%. Therefore, ANG-B is an efficient boron delivery agent, which has low cytotoxicity and high tumour-to-blood ratio. Based on these experimental results, we expected that ANG-B may leverage BNCT performance in clinical applications in future.

学科与关键词

关键词
Boron neutron capture therapy (BNCT)boron-peptide conjugatesangiopep-2binary radiation therapycancer medicine
相关
加载中…
  • A transdermal drug delivery system based on dissolving microneedles for boron neutron capture therapy of melanoma
    Li, Jiaxin; Wang, Xueyi*; Wang, Zhaoshuo; Zhao, Yu; Zhang, Ziyang; Li, Lanya; Ding, Dandan; Guo, Junshu; Zhang, Jinchao; Liu, Huifang*; Li, Zhenhua*Biomaterials Science, 2023, 11(23): 7568-7578.
  • Boron Neutron Capture Therapy
    Koji, ONO; Minoru, SUZUKI; Shinichiro, MASUNAGA; Natsuko, KONDO; Yoshinori, SAKURAI; Hiroki, TANAKA; Yuko, KINASHI; Akira, MARUHASHIRadioisotopes, 2012, 61(4): 209-222.被引 1
  • Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma
    Chen, Jiejian; Dai, Qi; Yang, QiYao; Bao, Xiaoyan; Zhou, Yi; Zhong, Haiqing; Wu, Linjie; Wang, Tiantian; Zhang, Zhicheng; Lu, Yiying; Zhang, Zhentao; Lin, Mengting; Han, Min*; Wei, Qichun*JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20(1): 102.被引 24
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2023-06-01
卷期
第 10 卷
页码
1199881
DOI
10.3389/fmed.2023.1199881
成果收录
SCIE

作者

  • X

    Xiang, Jing (第一作者)

    peking univ

  • M

    Ma, Lin

    shenzhen univ

查看全部 10 位作者收起作者
  • T

    Tong, Jianfei

    chinese acad sci

  • Z

    Zuo, Nan

    1 · harbin med univ

  • H

    Hu, Weitao

    hangzhou normal univ

  • L

    Luo, Yupeng

    shenzhen univ

  • L

    Liu, Junqi

    1 · zhengzhou univ

  • L

    Liang, Tianjiao

    chinese acad sci

  • R

    Ren, Qiushi (通讯)

    peking univ

  • L

    Liu, Qi (通讯)

    shenzhen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417